ClinicalTrials.Veeva

Menu

The Effect of the ALDH2 Gene Polymorphism on the Propofol Potency for Inducing Loss of Consciousness

Fudan University logo

Fudan University

Status

Unknown

Conditions

Propofol

Treatments

Drug: Propofol

Study type

Observational

Funder types

Other

Identifiers

NCT03762538
EAGLES (Other Identifier)

Details and patient eligibility

About

The aim of this study is to determine whether ALDH2 gene polymorphisms (G/G, G/A A/A) have effect on the potency of propofol.

Enrollment

100 estimated patients

Sex

Male

Ages

50 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA II

Exclusion criteria

  • ASA III-IV
  • OSAS
  • hepatic and renal insufficiency

Trial design

100 participants in 2 patient groups

G/G group
Description:
Patients who are determined to be G/G genotype.
Treatment:
Drug: Propofol
G/A A/A group
Description:
Patients who are determined to be G/A or A/A genotypes.
Treatment:
Drug: Propofol

Trial contacts and locations

0

Loading...

Central trial contact

Kefang Guo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems